Bioamber Inc (BIOAQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2017 | 12-2016 | 12-2015 | 12-2014 | 12-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -102,187 | -28,371 | -41,171 | -47,349 | -27,926 |
| Depreciation Amortization | 7,734 | 8,155 | 2,158 | 552 | 1,405 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | -61 |
| Accounts receivable | -3,675 | -5 | -581 | 278 | -159 |
| Accounts payable and accrued liabilities | 0 | 0 | -984 | 819 | -144 |
| Other Working Capital | -4,690 | -11,047 | 2,586 | 10,640 | -360 |
| Other Operating Activity | 73,028 | -6,348 | 5,793 | 12,607 | -280 |
| Operating Cash Flow | $-29,789 | $-37,616 | $-32,199 | $-22,453 | $-27,525 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -811 | -668 | -64,390 | -85,014 | -12,788 |
| Purchase Of Investment | N/A | N/A | -412 | 675 | N/A |
| Other Investing Activity | 0 | 0 | 0 | -678 | 0 |
| Investing Cash Flow | $-811 | $-668 | $-64,803 | $-85,018 | $-12,788 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | 28,037 | 29,914 | 43,872 | 27,833 |
| Debt Repayment | -19,048 | -15,312 | -16,059 | -25,000 | N/A |
| Common Stock Issued | 37,978 | 36,206 | 42,177 | 60,859 | 73,023 |
| Common Stock Repurchased | N/A | N/A | N/A | N/A | -140 |
| Other Financing Activity | -82 | -1,707 | -1,144 | -1,077 | -793 |
| Financing Cash Flow | $18,848 | $47,224 | $54,888 | $78,655 | $99,924 |
| Exchange Rate Effect | 224 | 246 | -1,956 | -3,870 | -954 |
| Beginning Cash Position | 16,160 | 6,974 | 51,043 | 83,728 | 25,072 |
| End Cash Position | 4,632 | 16,160 | 6,974 | 51,043 | 83,728 |
| Net Cash Flow | $-11,528 | $9,186 | $-44,069 | $-32,686 | $58,656 |
| Free Cash Flow | |||||
| Operating Cash Flow | -29,789 | -37,616 | -32,199 | -22,453 | -27,525 |
| Capital Expenditure | -811 | -668 | -64,390 | -85,014 | -12,788 |
| Free Cash Flow | -30,600 | -38,284 | -96,589 | -107,467 | -40,313 |